PuSH - Publication Server of Helmholtz Zentrum München

Kremb, S. ; Helfer, M. ; Heller, W. ; Hoffmann, D.* ; Wolff, H. ; Kleinschmidt, A. ; Cepok, S.* ; Hemmer, B.* ; Durner, J. ; Brack-Werner, R.

EASY-HIT: HIV full-replication technology forbroad discovery of multiple classes of HIV inhibitors.

Antimicrob. Agents Chemother. 54, 5257-5268 (2010)
Publ. Version/Full Text DOI PMC
Closed
Open Access Green as soon as Postprint is submitted to ZB.
HIV replication assays are important tools for HIV drug discovery efforts. Here, we present a full HIV replication system (EASY-HIT) for the identification and analysis of HIV inhibitors. This technology is based on adherently growing HIV-susceptible cells, with a stable fluorescent reporter gene activated by HIV Tat and Rev. A fluorescence-based assay was designed that measures HIV infection by two parameters relating to the early and the late phases of HIV replication, respectively. Validation of the assay with a panel of nine reference inhibitors yielded effective inhibitory concentrations consistent with published data and allowed discrimination between inhibitors of early and late phases of HIV replication. Finer resolution of the effects of reference drugs on different steps of HIV replication was achieved in secondary time-of-addition assays. The EASY-HIT assay yielded high Z' scores (>0.9) and signal stabilities, confirming its robustness. Screening of the LOPAC(1280) library identified 10 compounds (0.8%), of which eight were known to inhibit HIV, validating the suitability of this assay for screening applications. Studies evaluating anti-HIV activities of natural products with the EASY-HIT technology led to the identification of three novel inhibitory compounds that apparently act at different steps of HIV-1 replication. Furthermore, we demonstrate successful evaluation of plant extracts for HIV-inhibitory activities, suggesting application of this technology for the surveillance of biological extracts with anti-HIV activities. We conclude that the EASY-HIT technology is a versatile tool for the discovery and characterization of HIV inhibitors.
Impact Factor
Scopus SNIP
Web of Science
Times Cited
Scopus
Cited By
Altmetric
4.802
2.130
15
30
Tags
Annotations
Special Publikation
Hide on homepage

Edit extra information
Edit own tags
Private
Edit own annotation
Private
Hide on publication lists
on hompage
Mark as special
publikation
Publication type Article: Journal article
Document type Scientific Article
Keywords HUMAN-IMMUNODEFICIENCY-VIRUS; T-CELL LINE; IN-VITRO; NATURAL-PRODUCTS; GENE-EXPRESSION; DRUG-RESISTANCE; TYPE-1; INFECTION; TRANSCRIPTION; ACTIVATION
Language english
Publication Year 2010
HGF-reported in Year 2010
ISSN (print) / ISBN 0066-4804
e-ISSN 1098-6596
Quellenangaben Volume: 54, Issue: 12, Pages: 5257-5268 Article Number: , Supplement: ,
Publisher American Society for Microbiology (ASM)
Reviewing status Peer reviewed
POF-Topic(s) 30203 - Molecular Targets and Therapies
30202 - Environmental Health
Research field(s) Immune Response and Infection
Environmental Sciences
PSP Element(s) G-502700-001
G-504900-001
G-504900-002
Scopus ID 78649671314
PubMed ID 20876377
Erfassungsdatum 2010-11-17